Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006)

dc.contributor.authorCastanheira, Mariana
dc.contributor.authorJones, Ronald N.
dc.contributor.authorSader, Helio S. [UNIFESP]
dc.contributor.institutionJMI Labs
dc.contributor.institutionTufts Univ
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2016-01-24T13:51:26Z
dc.date.available2016-01-24T13:51:26Z
dc.date.issued2008-06-01
dc.description.abstractGram-positive bacterial strains (6710) consecutively collected during 2006 in hospitals located in the United States and Canada were tested by reference broth microdilution methods against daptomycin and comparison agents. Only 1 Staphylococcus aureus strain (0.01%) had nonsusceptible daptomycin MIC value as specified by published break points. S. aureus daptomycin MIC distributions from 2006 as compared with those of previous years did not show MIC creep. Resistance to other compounds, such as vancomycin, oxacillin and penicillin, did not adversely influence daptomycin activity. Daptomycin remains highly active against clinical Gram-positive isolates collected in North America. (C) 2008 Elsevier Inc. All rights reserved.en
dc.description.affiliationJMI Labs, N Liberty, IA 52317 USA
dc.description.affiliationTufts Univ, Sch Med, Boston, MA 02111 USA
dc.description.affiliationUniversidade Federal de São Paulo, Div Infect Dis, BR-04023900 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Div Infect Dis, BR-04023900 São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent235-239
dc.identifierhttp://dx.doi.org/10.1016/j.diagmicrobio.2008.01.016
dc.identifier.citationDiagnostic Microbiology and Infectious Disease. New York: Elsevier B.V., v. 61, n. 2, p. 235-239, 2008.
dc.identifier.doi10.1016/j.diagmicrobio.2008.01.016
dc.identifier.issn0732-8893
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/30700
dc.identifier.wosWOS:000256489400019
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofDiagnostic Microbiology and Infectious Disease
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.rights.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.subjectdaptomycinen
dc.subjectMRSAen
dc.subjectvancomycin resistanceen
dc.titleUpdate of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006)en
dc.typeinfo:eu-repo/semantics/article
Arquivos